Updated resource: unpicking the COVID-19 extremely vulnerable category for people affected by cancer

Latest from the Blog

NEW COURSE: Managing Physical Effects

NEW COURSE: Managing Physical Effects

Tuesday 5th January 2021 We are delighted to announce that the new Managing Physical Effects course is now available on GatewayC. According to Macmillan, at least 1 in 4 patients will experience consequences of their cancer or treatment that affect their quality of...

read more
GatewayC’s top tips from 2020

GatewayC’s top tips from 2020

Monday 4th January 2021 2020 certainly provided challenges and many new learning opportunities for primary care professionals across England. With this in mind, we have rounded up some of our most popular 2020 tips. Take a look below! COVID-19 and neutropenic sepsis...

read more

Related Posts

Meet the specialists: improving early diagnosis Q&A

Meet the specialists: improving early diagnosis Q&A

Friday 27th November 2020 Missed our free GatewayC webinar on Improving Early Diagnosis? Watch our recording here. In this webinar, GatewayC met Dr Anthony Cunliffe, Joint National Lead Macmillan GP Adviser, and Dr Ben Noble, East Midlands Cancer Alliance and Cancer...

read more

Wednesday 15th April 2020

People with certain cancers and those who have received or are receiving certain treatments are at risk of severe illness if they catch coronavirus (COVID-19). One Cancer Voice charities (in partnership with NHS England) have confirmed this includes:

  • Every patient undergoing active chemotherapy
  • Patients who have received chemotherapy in the last three months (advise patients to contact their care team to discuss their specific circumstances. In the meantime, patients should follow the Public Health England guidance on ‘shielding’ – in summary, stay at home and avoid face-to-face contact for a period of 12 weeks)
  • Patients with blood disorders who are immunocompromised but not receiving chemotherapy
  • Patients having radiotherapy for metastatic lung tumours
  • Patients with metastatic cancer in the lungs who are not currently receiving treatment (if they have not received a letter, advise patients to contact their care team to discuss their specific circumstances. In the meantime, patients should follow the Public Health England guidance on ‘shielding’ – in summary, stay at home and avoid face-to-face contact for a period of 12 weeks)
  • Patients having any targeted treatments (more than just antibody treatments) and anti-angiogenesis targeted drugs
  • Transplant patients (if they have had a transplant within the last 6 months, and if they are taking any immunosuppression)
  • Patients with a rare disease and that disease significantly increases their risk of infection

Find out more:

LinkedIn | Twitter | Facebook

Latest from the Blog

NEW COURSE: Managing Physical Effects

NEW COURSE: Managing Physical Effects

Tuesday 5th January 2021 We are delighted to announce that the new Managing Physical Effects course is now available on GatewayC. According to Macmillan, at least 1 in 4 patients will experience consequences of their cancer or treatment that affect their quality of...

read more
GatewayC’s top tips from 2020

GatewayC’s top tips from 2020

Monday 4th January 2021 2020 certainly provided challenges and many new learning opportunities for primary care professionals across England. With this in mind, we have rounded up some of our most popular 2020 tips. Take a look below! COVID-19 and neutropenic sepsis...

read more

Related Posts

Meet the specialists: improving early diagnosis Q&A

Meet the specialists: improving early diagnosis Q&A

Friday 27th November 2020 Missed our free GatewayC webinar on Improving Early Diagnosis? Watch our recording here. In this webinar, GatewayC met Dr Anthony Cunliffe, Joint National Lead Macmillan GP Adviser, and Dr Ben Noble, East Midlands Cancer Alliance and Cancer...

read more